VIDEO: A-DREAM trial shows promising benefit of ADT interruption in prostate cancer

CHICAGO — In this video, Matthew R. Zibelman, MD, discusses the A-DREAM trial, which found that androgen deprivation therapy interruption resulted in testosterone recovery for two-thirds of patients with metastatic prostate cancer.Findings were presented at ASCO Annual Meeting.